Clinical Trial Update: Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating heat-activated liposomal doxorubicin with radiofrequency ablation for primary or metastatic liver tumors; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Cancer

Drugs mentioned

• ThermoDox (doxorubicin liposome)

Snippet

Sponsor: National Institutes of Health Clinical Center (CC) | Conditions: Liver Cancer, Metastatic Cancer | Phase 1 | Status: COMPLETED